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Hypoxanthine phosphoribosyltransferase (HPRT1) is a key enzyme in the purine salvage pathway, and mutations in HPRT1 cause Lesch–
Nyhan disease. The studies described here utilized targeted comparative mapping and sequencing, in conjunction with database searches, to
assemble a collection of 53 HPRT1 homologs from 28 vertebrates. Phylogenetic analysis of these homologs revealed that the HPRT gene family
expanded as the result of ancient vertebrate-specific duplications and is composed of three groups consisting of HPRT1, phosphoribosyl
transferase domain containing protein 1 (PRTFDC1), and HPRT1L genes. All members of the vertebrate HPRT gene family share a common
intron–exon structure; however, we have found that the three gene groups have distinct rates of evolution and potentially divergent functions.
Finally, we report our finding that PRTFDC1 was recently inactivated in the mouse lineage and propose the loss of function of this gene as a
candidate genetic basis for the phenotypic disparity between HPRT-deficient humans and mice.
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evolution [1]. Duplicate genes can improve the fitness of an
organism by an increase in gene dosage, creating new genes
with new functions by neofunctionalization [1], improving
upon the function of a single ancestral gene by subfunctiona-
lization [2], or by a combination of one or more of these
mechanisms [3]. Conversely, gene inactivation is also thought
to be important for adaptive evolution [1,4]. For example, loss
of function alleles can confer resistance to infectious disease in
humans and mice (reviewed in [4,5]).
Among vertebrates, gene inactivation appears to be a
recurring theme in the purine metabolic pathway. Though
purine metabolism is an ancient and fundamental biological
process, differential loss of enzymes in this pathway has led to
variation in the end product of purine metabolism within
vertebrates [6], and hypotheses on the adaptive advantage that⁎ Corresponding author. Fax: +1 404 727 3949.
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doi:10.1016/j.ygeno.2006.07.003these gene loss events might confer have been advanced. For
example, because hominoids, birds, and terrestrial reptiles lack
a functional urate oxidase gene, the end product of purine
metabolism in these species is uric acid. In the case of
hominoids, it has been argued that, since uric acid is an effective
antioxidant, high levels of uric acid in plasma may be a
contributing factor to an increase in human lifespan and a
decrease in the incidence of age-related cancer [7]. Due to the
similarity in chemical structure to stimulants such as caffeine, it
has also been debated whether an increase in uric acid plasma
levels might be important for the increased cognitive abilities of
hominoids [8,9]. Though loss of function mutations in the
purine metabolic pathway cause several human diseases [10],
null alleles of two genes in this pathway, adenosine mono-
phophosphate deaminase 1 and 3 (AMPD1 and AMPD3), are
segregating at frequencies up to 19% in human populations
[11,12]. Strikingly, heterozygotes for the AMPD1 null allele
have been reported to be associated with better clinical
outcomes after congestive heart failure [13] and are less likely
to die of cardiovascular failure once diagnosed with coronary
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loss of gene function modified the purine metabolic pathway in
the distant past but it also may be a mechanism by which
contemporary human populations are adaptively evolving. Here
we have focused on elucidating the history of gene duplication
and gene loss of the purine salvage enzyme, hypoxanthine
phosphoribosyltransferase 1 (HPRT1; EC 2.4.2.8), in vertebrates.
HPRT1 is widely conserved across eukaryotes and prokar-
yotes and has a central role in the generation of purine
nucleotides through the purine salvage pathway. HPRT1 is a
phosphoribosyl transferase domain (pfam00156) containing
protein that catalyzes the conversion of hypoxanthine to
inosine monophosphate (IMP) and guanine to guanosine
monophosphate (GMP) via the transfer of the 5-phosphoribosyl
group from 5-phosphoribosyl 1-pyrophosphate (PRPP).
HPRT1 is an X-linked gene in placental mammals and
marsupials [15], whereas in other vertebrates, such as chicken,
it is located on an autosome [16]. In humans, HPRT1
deficiency results in one of three disorders, the most severe
of which is Lesch–Nyhan disease (LND; OMIM 300322).
LND patients exhibit hyperuricemia, neurological dysfunction,
and self-injurious behavior, and, although there is a good
correlation between the level of HPRT1 activity and, the
severity of the disease, the etiology of the neurological
phenotypes has yet to be established [17]. In contrast,
HPRT1 deficiency in the mouse does not lead to the
neurological dysfunction or self-injurious behavior seen in
humans [18,19].
To date, studies of the HPRT1 duplication events in
vertebrates have primarily focused on mammalian processed
pseudogenes, which are likely the result of relatively recent
retrotranspositions of the HPRT1 messenger RNA. Though in
at least one instance an HPRT1 gene duplicate derived from a
retrotransposition event was shown to encode a protein [20],
until recently no other functional paralogs of HPRT1 had been
described [21]. Using a bioinformatic approach, Nicklas [21]
found an uncharacterized gene on human chromosome 10 with
68% amino acid identity to HPRT1 and a similar intron–exon
structure, called phosphoribosyl transferase domain containing
protein 1 (PRTFDC1), which is likely an ancient paralog of
HPRT1. Here we report the systematic characterization of the
vertebrate HPRT gene family, including the gene duplications
and gene inactivation events that have led to the extant variation
in HPRT gene family content across vertebrates, and discuss the
potential importance of this variation for the development of a
genetic model of LND.
Results
Compilation of the HPRT gene family data set
Initial database searches comparing the human HPRT1
protein to a variety of vertebrate genomes revealed the
presence of up to four HPRT homologs. As the first step
toward resolving the evolutionary relationships and history
of the vertebrate HPRT gene family, we used targeted
mapping and sequencing and database searches to system-atically assemble a large collection of these genes from a
diverse panel of vertebrates (see Supplementary Table 1). In
particular, a bacterial articficial chromosome (BAC)-based
targeted mapping and sequencing approach was used to
identify 20 HPRT gene family members from 15 species.
The sequences of 33 additional HPRT gene family members
were also identified from publicly available genomic and/or
EST and cDNA databases. In total, 53 predicted or known
cDNA sequences from 28 species and 44 genomic sequences
from 25 species were collected for characterization of the
vertebrate HPRT gene family.
Phylogeny of the HPRT gene family
Initial sequence comparisons and gene distributions among
the collection of HPRT family members were consistent with
the expected widespread distributions of HPRT1 and
PRTFDC1, suggesting an ancient origin for both genes.
However, no more than one HPRT gene family member could
be detected in the genomes of three invertebrates, Ciona
intestinalis, Caenorhabditis elegans, and Drophila melanoga-
ster, further suggesting that PRTFDC1 might have originated
as the result of a duplication event involving the HPRT1
locus just prior to the most recent common ancestor (MRCA)
of vertebrates. In addition, while in general two functional
HPRT gene family members were found in tetrapod genomes,
up to four HPRT gene family members were detected in fish,
indicative of additional gene duplications or losses.
To resolve the evolutionary relationships of the HPRT
homologs and estimate the timing of gene duplications or gene
loss events in vertebrates, we first constructed a consensus tree
using the amino acid sequences from our collection of functional
HPRT gene family members (Supplementary Fig. 1). Based on
this protein consensus tree, the genes within the HPRT gene
family can be categorized into three groups: (1) HPRT1, which
contains previously characterized HPRT1 genes and newly
identified genes from all of the vertebrate lineages sampled; (2)
PRTFDC1, which also contains genes from all the vertebrate
lineages sampled and up to two genes (PRTFDC1a and
PRTFDC1b) from some species of fish, including fugu,
tetraodon, and trout; and (3) HPRT1L, which is exclusively
composed of genes from fish.
Though the analysis of the amino acid sequences showed
strong support for three distinct groups of genes within the
vertebrate HPRT gene family, the branching order within the
groups was not well resolved. To better elucidate the
evolutionary relationships between the genes within each
group, we also constructed a concensus tree from the
nucleotide sequence of the protein coding regions of each
functional gene (Fig. 1). As was observed in the protein
tree, the phylogeny based on the nucleotide sequences
strongly supported the HPRT1, PRTFDC1, and HPRT1L
gene groups. In addition, the branching order within each
group and clustering of fish, amphibian, bird and alligator,
and mammalian genes were consistent with the expected
species phylogeny [22]. Thus, the phylogeny of the HPRT
gene family indicates that gene duplication(s) prior to the
Fig. 1. Phylogeny of the HPRT gene family. The nucleotide sequence of the protein coding portion of each HPRT gene family member was used to build a consensus
tree using Bayesian, maximum parsimony (MP), and maximum likelihood (ML) methods. Major nodes are labeled with the percentage bootstrap support for the
Bayesian, MP, and ML methods, respectively. The branch lengths were estimated by ML and represent substitutions per site.
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primary basis for the expansion of the HPRT gene family
into three distinct groups and for the current taxonomic
distribution. The inferred timing of duplications within the
HPRT gene family therefore coincides with time points
hypothesized to be associated with large-scale duplications
in the vertebrate lineage [23].Genomic structure of the HPRT gene family
Vertebrate orthologs display a high degree of conservation of
intron–exon structure [24]. In contrast, the size and repetitive
element content of orthologous introns tend to be strongly
correlated with the genome size and repetitive element content
of the individual species and thus can be quite divergent
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the genomic level, we inferred the intron–exon structure and
intronic sequence composition of 44 HPRT family members
from 25 species (see Methods).
In support of their common evolutionary history, the intron–
exon structures of the genes within the HPRT gene family were
found to be conserved across the entire family. Specifically, the
genomic organization of each HPRT gene family member
consists of nine coding exons, of which only exons 1, 3, and 4
were observed to vary in size (Fig. 2a). However, this conserved
gene structure was limited to vertebrates. For example, the
HPRT homolog in C. intestinalis is an intronless gene, while the
C. elegans homolog contains three introns. Thus, the conserved
intron–exon structure within this gene family likely represents
an ancestral genomic organization that predates the MRCA of
vertebrates.
In contrast, the intron size and composition were found to be
highly divergent in the HPRT gene family members, and there
was a clear correlation between the genome size and the total
size of the HPRT1 (r2 =0.65), PRTFDC1 (r2 =0.86), and
HPRT1L (r2 =0.99) loci, with the genes from the “large”
mammalian genomes spanning the greatest chromosomal
intervals and the orthologs from the “small” puffer fish genomes
the least (Fig. 2b and Supplementary Table 2). Similarly, the
observed repetitive element content of the HPRT1, PRTFDC1,Fig. 2. Genomic structure and sequence composition of the HPRT gene family loci
consists of nine coding exons. Variation in exon length (*) was noted for exon 1 (1
tetraodon PRTFDC1a genes), and exon 4 (66 or 63 bp in the fugu and tetraodon HPR
HPRT1L loci.and HPRT1L loci were also consistent with available genome-
wide averages and variation across species [26–31] (Fig. 2b).
Interestingly, there was an unusual pattern of relative intron
size in the HPRT1 and PRTFDC1 intraspecies paralogs. Within
the mammals and birds, the PRTFDC1 loci were 2.1- to 3.5-
fold larger than the HPRT1 loci. However, with the exception of
zebrafish which had a PRTFDC1/HPRT1 size ratio of 2.8, the
other fish and amphibian paralogous gene pair size ratios were
between 1.1 and 1.2 (Fig. 2b). While conservation of local
variation in the rate of DNA gain and loss at the PRTFDC1 and
HPRT1 loci could account for this difference in amniotes,
surprisingly the size differential was not evenly distributed
across the locus. Instead the size difference mapped primarily to
a single intron, intron 3, which was 3.6- to 11.2-fold larger in
PRTFDC1 than in HPRT1. The length variation in the
paralogous third intron in PRTFDC1 and HPRT1 accounted
for 44–91% of the overall size differences, which in all cases
was significantly higher than expected (p<1e-25, df=1, χ2 test)
if all the paralagous introns had expanded/contracted propor-
tionally. Thus, while the evolution of the vertebrate HPRT gene
family introns was strongly correlated with genome-wide
properties, within the amniotes, intron 3 was associated with
an unusual pattern of evolution, perhaps consistent with a
signature of differential selection influencing intron size within
that clade.. (a) The consensus intron–exon structure of the vertebrate HPRT gene family
8, 21, 27, 30, 33, 45, 48, 51 or 60 bp), exon 3 (184 or 181 bp in the fugu and
T1L genes). (b) Genomic sequence composition of the HPRT1, PRTFDC1, and
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The only function associated with the HPRT gene family is
the ancient enzymatic role of HPRT1 as a phosphoribosyl-
transferase in the purine salvage pathway. Analysis of the
domain content within the HPRT gene family predicted that all
of the family members contain a phosphoribosyl transferase
domain (pfam00156). In addition, HPRT1, PRTFDC1, and
HPRT1L proteins overall are quite similar, with the average
percentage identity between intraspecies HPRT1-PRTFDC1,
HPRT1-HPRT1L, and PRTFDC1-HPRT1L paralogs equal to
65, 75, and 56%, respectively. We therefore sought to ascertain
whether each gene family member had likely retained or lost the
known enzymatic function of HPRT1. Specifically, we
hypothesized that the genes within the HPRT1 group would
have retained the ancestral enzyme activity, while the others
might have divergent function(s). To test this hypothesis, we
compared the amino acid sequence of each gene at 11 conserved
residues that flank or are near the active site and are presumed to
be especially critical for HPRT function [32]. As expected, the
HPRT1 orthologs with experimentally validated HPRT activity,
such as those from human and chicken, had no amino acid
substitutions at the 11 conserved positions. Moreover, the 11
critical amino acids were completely conserved in all the
HPRT1 genes sampled, consistent with the hypothesis that those
proteins have retained the ancestral function in the purine
salvage pathway. In contrast, none of the PRTFDC1 or HPRT1L
proteins showed conservation at all 11 critical sites, suggesting
that each of those proteins had lost the ancestral HPRT
enzymatic activity (Supplementary Table 3). Thus, the predicted
enzymatic function, or lack thereof, was consistent with our
phylogenetic classification of the HPRT gene family.
Evolutionary rates in the HPRT gene family
Because the proteins encoded by the PRTFDC1 and
HPRT1L genes are predicted to have lost their ancestral HPRT
enzymatic activity, it is likely that these duplicate genes have
been retained in the genome by virtue of evolving a new
function and thus that distinct selective forces have acted on the
HPRT1, PRTFDC1, and HPRT1L genes. The rate at which a
gene has evolved can be inferred by calculating the ratio of
nonsynonymous (Ka) to synonymous (Ks) substitutions, i.e., Ka/
Ks. By applying a maximum-likelihood method to the nucleo-
tide-based phylogeny shown in Fig. 1 (see Methods), we
estimated the Ka/Ks rate ratio for each of the three groups of
genes and found that the HPRT1 genes had the slowest rate of
evolution, Ka/Ks=0.024, HPRT1L an intermediate rate, Ka/
Ks=0.053, while PRTFDC1 displayed the highest rate of
evolution, Ka/Ks=0.098. A comparison between a model in
which each of the three groups had a distinct Ka/Ks value versus
a model in which all three groups had the same Ka/Ks value
indicated that the observed differences in the rate of evolution in
the three groups was significant (2Δl= 125.83, df= 2,
p=4.74×10−28). Further tests directly comparing the Ka/Ks
rates in all possible pairs of the three gene groups also supported
the hypothesis that there was significant variation in the rate ofevolution in these groups (p<0.003; data not shown). Thus,
while all three gene groups were found to be evolving under
strong purifying selection, each group was associated with a
distinct rate of evolution.
Having discovered evolutionary rate differences in the three
groups of genes, we sought to determine whether significant
changes in the rate of evolution could be detected within the
large sets of HPRT1 and PRTFDC1 genes. A systematic
comparison of the rates of evolution in genes from the major
taxonomic clades, i.e., tetrapods versus fish, and then a series of
pairwise comparisons within tetrapods among placental mam-
mals (eutherians), marsupials, birds, and amphibians did not
reveal any significant variation in the rate of evolution within
the set of PRTFDC1 genes. However, analogous comparisons
with the HPRT1 genes were able to partition this group by
taxonomy and evolutionary rate into two distinct clusters; the
eutherians, Ka/Ks=0.052, and the remaining tetrapods and all
fish, Ka/Ks=0.015 (2Δl=37.68, df=1, p=8.34×10
−10). Thus,
while these results suggest that the rate of evolution of the
PRTFDC1 genes has been fairly uniform, the rate variation
detected among the HPRT1 genes is a potential signal of a
recent relaxation of selection, or positive selection, on HPRT1
in the eutherian lineage.
Inactivation of PRTFDC1 in mouse
A mouse PRTFDC1 locus was readily identified on mouse
chromosome 2 at the predicted position within a large block of
conserved synteny with the human, rat, dog, and chicken
genomes [27–29,33]. However, closer examination of the
coding sequence revealed that the mouse PRTFDC1 gene was
inactive. Specifically, the predicted mouse PRTFDC1 open
reading frame inferred from interspecies alignments to the
assembled C57BL/6J genome was disrupted by three indepen-
dent mutations: a missense mutation in the first exon that
eliminates the start codon, a frameshift mutation in exon 2
caused by a 5-bp insertion that leads to an early stop codon and
truncation of three quarters of the protein, and a nonsense
mutation in exon 8 that eliminates the final 11 amino acids.
Furthermore, while interspecies genomic and cDNA alignments
were consistent with a conserved intron–exon structure,
including consensus splice acceptor and donor sites, no
mouse ESTs or cDNAs representing a PRTFDC1 mRNA
were identified by thorough searches of public databases. In
contrast, 147 and 38 ESTs or cDNAs have been assigned to the
human and rat PRTFDC1 UniGene [34] clusters, respectively.
Because PRTFDC1 is predicted to be functional in rat and all
other mammals surveyed, we hypothesized that the inactive
allele observed in the inbred C57BL/6J strain had arisen in the
mouse lineage since the MRCA of mice and rats. To more
precisely time the inactivation event, we sought to determine
whether PRTFDC1 was also inactive in other mouse species by
PCR amplifying and sequencing the coding exons of the
PRTFDC1 gene from a diverse panel of wild-derived mice (see
Methods). At least one inactivating mutation in the PRTFDC1
gene was observed in all eight strains surveyed (Table 1),
suggesting that the inactive PRTFDC1 allele predates the
Table 1
Inactivating mutations in the mouse PRTFDC1 gene
Mouse strain Mutation a
1A>G 131_132insACCAC 619C>T
C57BL/6J + + +
WSB/EiJ n.a. − +
CZECH1/EiJ + + +
MOLC/RkJ + + +
CAST/EiJ + + +
SPRET/EiJ + + −
PANCEVO/EiJ + n.a. −
Mus caroli/EiJ n.a. + b +
Mus pahari/EiJ n.a. − +
(+) Mutation was present; (−) mutation was absent; (n.a) sequence was not
available.
a The position of the mutations are based on coordinates from the human
PRTFDC1 coding sequence (GenBank Accession No. NM_020200) and the
inferred mutation by comparison to the predicted rat coding sequence
(GenBank Accession No. XM_214518).
b The mutation in Mus caroli/EiJ is 131_132insACCCCAC.
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also used the method described in [35] to date the emergence of
the inactive PRTFDC1 allele (see Methods). In this case, based
on an empirically determined divergence time between mouse
and rat of 23.5 million years, we estimate that the inactivation of
the mouse PRTFDC1 allele occurred 13.3 MYA. Thus, the most
parsimonious explanation for these results is that the PRTFDC1
gene was inactivated in the mouse lineage after the divergence
from the MRCA of mouse and rat. The inactive allele then
became fixed in an ancestral population of mice prior to the
divergence of the Mus lineages from which all laboratory and
wild-derived strains of mice were derived.
Discussion
As a result of a combination of important properties
including enzymatic function in the purine salvage pathway,
development and subsequent widespread use of HPRT1 as a
somatic cell genetic marker, and clinical significance of HPRT1
deficiency in human disease, HPRT1 is perhaps one of the best
characterized genes in the human genome. Here we have
reported for the first time a systematic study of the evolution of
the HPRT1 locus and HPRT gene family in vertebrates.
Phylogenetic analysis indicated that the vertebrate HPRT
gene family consists of three groups of genes: HPRT1, which
encodes proteins with predicted or known HPRT activity, and
PRTFDC1 and HPRT1L, which arose as the result of the
duplication of the HPRT1 locus. In particular, we favor a model
in which a duplication of the HPRT1 locus prior to the MRCA
of vertebrates some ∼450 MYA gave rise to PRTFDC1.
Subsequent duplication of the PRTFDC1 locus in the fish
lineage followed by the differential retention or loss of the gene
duplicates then led to the observation that some fish genomes
have two PRTFDC1 genes, while others have only one. Both of
these interpretations are compatible with the whole-genome
and/or other large-scale duplication events hypothesized to have
occurred prior to the MRCA of vertebrates and subsequently ina common ancestor of just the ray-finned fish [23]. In contrast,
though the HPRT1L was found only in fish, the position of the
HPRT1L orthologs within the tree suggests an origin prior to the
divergence of fish and tetrapods. Thus, HPRT1L may have
arisen as the result of a duplication event prior to the MRCA of
vertebrates but was subsequently lost in the tetrapod lineage.
Alternatively, HPRT1L may have arisen more recently by
duplication in the fish lineage, but the tree-building methods
that we used here did not faithfully reconstruct the true history
of this gene. Nonetheless, our findings indicate that three
ancient duplication events resulted in the expansion of the
vertebrate HPRT gene family into three groups: HPRT1,
PRTFDC1, and HPRT1L.
All members of the vertebrate HPRT gene family share a
common intron–exon structure, suggesting that the extant
genomic organization of these genes has been conserved over a
cumulative evolutionary timescale of several billion years. In
contrast, the intron length and composition of orthologs within
each of the three gene clades were highly divergent and
representative of genome-wide differences between the species.
Intraspecies comparisons of paralogous HPRT1 and PRTFDC1
loci revealed a clear difference in the size of the introns of these
genes that was primarily restricted to intron 3 in mammals and
birds. Though the length of paralogous introns is not tightly
correlated [36], the general conservation of the length variation
of HPRT1/PRTFDC1 intron 3 across mammals and birds is
perhaps suggestive of selection acting at the level of genomic
size [37].
The function(s) of the PRTFDC1 and HPRT1L genes are
unknown, but, like HPRT1, both PRTFDC1 and HPRT1L
proteins contain a phosphoribosyl transferase domain. How-
ever, comparison of the amino acid composition at conserved
sites critical for HPRT enzymatic activity predicted that all
PRTFDC1 and HPRT1L proteins have lost this ancestral
function. In addition, the ability to select for the presence or
absence of HPRT activity, for example in human and chicken
cell lines which also contain the PRTFDC1 gene, provides
indirect experimental evidence that the function of PRTFDC1 is
not redundant with HPRT1 in this regard. Therefore, PRTFDC1
and HPRT1L have likely been retained in the genome by virtue
of acquiring a new and yet to be determined function as
predicted by the neofunctionalization model [1].
Similar to most protein coding genes, the members of the
HPRT gene family were found to be evolving under strong
purifying selection (Ka/Ks<0.1) [28]. Significant variation in
the rate of protein evolution was observed between the three
groups of genes and among the HPRT1 genes. In particular, the
eutherian HPRT1 genes were found to be evolving at an
elevated rate relative to the rates of other tetrapods and fish and
likely to the ancestral rate of evolution. One potential cause of
the observed elevated rate is the position of HPRT1 on the X
chromosome in eutherians compared to its autosomal linkage in
most other vertebrate genomes. However, though not statisti-
cally significant, it should be noted that the marsupial HPRT1
genes, which are also X-linked [15], were evolving at a slower
rate than their eutherian orthologs (Ka/Ks=0.02 versus Ka/
Ks=0.052, 2Δl=1.52, df=1, p=0.08). Thus, other factors are
140 A.C. Keebaugh et al. / Genomics 89 (2007) 134–142also likely involved in this observed difference in evolutionary
rate of eutherian HPRT1 orthologs.
Finally, we detected a recent gene inactivation event specific
to theMus lineage in PRTFDC1. Without any knowledge of the
function of this gene, hypotheses on the basis of the fixation of
the PRTFDC1 null allele in mice are limited to general
mechanisms, including genetic drift, hitchhiking, or positive
selection. Regardless of the means by which PRTFDC1
function was lost in the mouse lineage, the inactivation and
fixation of this null allele are strikingly reminiscent of the
presumably adaptive gene inactivations that have occurred in
the vertebrate purine metabolic pathway [6]. While the potential
selective advantage that the loss of PRTFDC1 function did or
did not confer to an ancestral population of mice cannot be
directly tested, we propose that the lack of PRTFDC1 activity in
the mouse is a strong genetic candidate for the phenotypic
difference between HPRT-deficient humans and mice. In
particular, we hypothesize that the presence of PRTFDC1 is
required for the manifestation of the severe neurological
phenotypes observed in HPRT-deficient humans, which are
absent in HPRT-deficient mice. In other words, the progression
of the neurological symptoms is dependent on the mis-
regulation of PRTFDC1 either by the absence of direct
protein–protein interactions with HPRT1 or, indirectly, for
example, via the increased levels of PRPP in HPRT-deficient
cells which have been shown to upregulate the activity of other
phosphoribosyl transferase domain containing proteins [17].
Our model therefore has two testable hypotheses: (1) that HPRT
deficiency in any other mammal will likely result in a
neurological phenotype and (2) that the reintroduction of an
active copy of PRTFDC1 into HPRT-deficient mice will lead to
a neurological phenotype and thus a genetic model for LND.
In conclusion, a comparative genomics approach was used to
determine a detailed evolutionary history of the HPRT gene
family in vertebrates. The series of “evolutionary alleles” [38]
for the HPRT1 and PRTFDC1 genes reported here in the form
of genomic clones and sequences from a diverse set of
vertebrates will provide invaluable resources for future experi-
mental studies designed to dissect and compare the function of
these genes, particularly in light of their evolutionary history
and role in human disease.
Methods
Targeted mapping and sequencing
A BAC-based targeted mapping and sequencing approach was used to
sequence chromosomal segments containing HPRT gene family members.
Briefly, genomic libraries were screened as described in [39] to identify
bacterial artificial chromosome clones containing the HPRT1 or PRTFDC1
loci. Selected clones were shotgun sequenced and then refined by comparative-
grade finishing efforts to produce high-quality sequence in ordered and
oriented contigs [40].
Database searches for additional HPRT gene family members
Additional HPRT gene family genomic loci were identified in public
genomic databases, NCBI (http://www.ncbi.nlm.nih.gov) and the UCSC
Genome Browser (http://www.genome.ucsc.edu), by sequence similarity toknown HPRT1 and PRTFDC1 proteins. Full-length cDNAs were also identified
by sequence similarity searches to the NCBI and TIGR (http://www.tigr.org/tdb/
tgi/) gene and EST databases. The source of each gene sequence is listed in
Supplementary Table 1.
Genomic sequence annotation and analysis
The intron–exon structure of each gene was inferred by cDNA–genomic
(Spidey [41]) and/or genomic–genomic (BLASTZ [42]) alignments. For HPRT
gene family members where no cDNAs were available, interspecies alignments
were used to infer the predicted open reading frame, protein, and gene structure.
The repetitive element content of each locus was determined with RepeatMasker
(http://www.repeatmasker.org) and supplemented with species-specific repeat
libraries for armadillo, bat, elephant, opossum, platypus, and rabbit from (ftp://
ftp.ebi.ac.uk/pub/databases/ensembl/encode/repeat_libraries/). The repeat
masking process was performed on species lacking a repetitive element
database using the repetitive element library from the most closely related
species available.
The annotated size of the individual gene loci was defined as the distance
between the start and the stop codons. In cases where the first exon was missing
from the genomic assembly, interspecies alignments were used to identify the
most 5’ intron 1 sequence available and subsequently used to estimate the locus
size. To measure the gene–genome size correlations, genome size estimates
were based on whole-genome sequence assemblies, the Animal Genome Size
Database (http://www.genomesize.com), and the literature [43] (see Supple-
mentary Table 2).
Protein domain analysis
The domain content of each predicted protein was inferred by comparison to
the cdd.v2.06 protein domain database with the NCBI conserved domain search
tool [44].
Phylogenetic analysis
The inferred amino acid sequences were aligned with ClustalX [45] and
the resulting alignments were manually edited and used to estimate the
maximum parsimony (MP), maximum likelihood (ML), and neighbor
joining phylogenies with Phylip (version 3.64) under the default parameters.
For maximum likelihood and neighbor joining analyses the amino acid
substitution matrix of D.T. Jones, W.K. Taylor, and J.M. Thornton [46] was
used. Bootstrap support was established from 1000 pseudo-replicate data
sets. The protein alignments were converted to nucleotide alignments with
CodonAlign (http://www.sinauer.com/hall/). Heuristic tree searching was
preformed on the nucleotide alignments under maximum parsimony,
maximum likelihood, and Bayesian analysis. Maximum parsimony was
implemented in Phylip (version 3.64). For maximum likelihood analysis, the
program TREE PUZZLE (version 5.2) [47] and the tree searching algorithm
quartet puzzling were used to estimate the maximum likelihood tree using
the GTR+Γ+I model of substitution. For both maximum parsimony and
maximum likelihood, bootstrap support was established from searches on
1000 pseudo-replicate data sets. Tree searching was also implemented in
MrBayes (version 3.1) [48]. Model parameters were estimated under the
GTR+Γ+I model and the default priors used. Four chains were run
simultaneously for 3,000,000 generations, with trees sampled every 1000
generations. After discarding the first 1500 sampled trees (“burn-in”), 1500
replicates were used to obtain clade credibility. For all methods, only nodes
with greater than 50% bootstrap support were resolved. A majority rules
consensus tree was constructed from the three methods using the “consense”
program in Phylip. Branch lengths were then computed in the program
“baseml” in PAML (version 3.14) [49]. For all tree building methods gaps
were excluded from the analysis and the C. intestinalis HPRT gene was
used as the outgroup. Finally, a maximum likelihood method implemented
by the “codeml” program in PAML was used to estimate the rates of
evolution at nonsynonymous (Ka) and synonymous (Ks) sites in the coding
sequences. Likelihood ratio tests were used to compare models in which the
number of Ka/Ks rates varied within the tree.
141A.C. Keebaugh et al. / Genomics 89 (2007) 134–142Sequencing the mouse PRTFDC1 exons
Genomic DNA from wild-derived inbred mouse strains was purchased from
The Jackson Laboratory and used as templates to individually PCR amplify the
PRTFDC1 exons. PCR amplicons were then isolated, sequenced, and compared
to the C57BL/6J genomic sequence. The panel of genomic DNA includedM. m.
domesticus,WSB/EiJ;M.m. musculus, CZECH1/EiJ;M.m.molossinus,MOLC/
RkJ; M. m. castaneous, CAST/EiJ; M. spretus, SPRET/EiJ; M. spicilegus,
PANCEVO/EiJ; Mus caroli/EiJ; and Mus pahari/EiJ. The sequences of the
primers used to amplify each mouse PRTFDC1 exon are available upon request.
Molecular dating of the mouse PRTFDC1 inactivation event
The method described in [35] was used to date the inactivation of the mouse
PRTFDC1 ortholog and assumes a model in which prior to inactivation the null
allele was evolving under selective pressure similar to that of closely related
functional orthologs and then neutrally after inactivation. In the case of the
inactive mouse PRTFDC1 allele, the mouse lineage Ka would be expected to
equal fNk(t –t1)+k t1, where fN=Ka/Ks (in the rat+ rodent lineages), k=neutral
mutation rate [the average dS of the mouse+rodent and rat+ rodent lineages/
t=the time since the MRCA of mouse and rat (the average dS of the mouse
and rat lineages/k)], and t1=the time since PRTFDC1 inactivation. To derive the
values necessary to solve for t1, we used “codeml” from the PAML software
package to analyze alignments of the coding region excluding the positions
corresponding to the 5-bp frameshift insertion and nonsense codon in the mouse
PRTFDC1 gene between mouse, rat, human, and opossum. Using the estimate
of 88 MYA as the time since the MRCA of rodents and human [50], we solved
the equation for t1=[((mouse lineage Ka)/k) – fNt] / (1 – fN) with the values t1=
[((0.0674) / (((0.3665+0.4773) / 2) / 88×106) – ((0.0723) (((0.0570+0.1679) /
2) / 4.794×10−9))] / (1 – 0.0723)=13.3 MYA.Acknowledgments
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